Provided by Tiger Trade Technology Pte. Ltd.

BridgeBio Pharma, Inc.

67.91
-0.2300-0.34%
Volume:3.67M
Turnover:248.79M
Market Cap:13.09B
PE:-16.23
High:69.50
Open:67.87
Low:67.10
Close:68.14
52wk High:84.94
52wk Low:28.33
Shares:192.71M
Float Shares:151.20M
Volume Ratio:1.07
T/O Rate:2.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.1844
EPS(LYR):-2.8793
ROE:-1789.67%
ROA:-43.47%
PB:-6.77
PE(LYR):-23.59

Loading ...

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
1 hour ago

BridgeBio Pharma CEO Neil Kumar Disposes of Common Shares

Reuters
·
14 hours ago

Blue Owl, Genuine Parts, And Okta Are Among Top 10 Large Cap Losers Last Week (Feb. 16-Feb. 20): Are the Others in Your Portfolio?

Benzinga
·
Feb 22

BridgeBio Pharma Inc expected to post a loss of 74 cents a share - Earnings Preview

Reuters
·
Feb 21

BridgeBio off lows as traders discuss conference appearance

TIPRANKS
·
Feb 21

BridgeBio Pharma Director Scott Randal W. Reports Common Share Disposal

Reuters
·
Feb 19

Bank of America Securities Sticks to Its Buy Rating for BridgeBio Pharma (BBIO)

TIPRANKS
·
Feb 18

BridgeBio Pharma Grants Equity Awards to 34 New Employees

Reuters
·
Feb 18

BridgeBio Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Feb 18

BridgeBio Pharma Inc. to announce fourth quarter and full year 2025 financial results and business update

Reuters
·
Feb 17

BridgeBio Pharma Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Feb 17

BridgeBio Pharma, Inc. : H.c. Wainwright Raises Target Price to $100 From $90

THOMSON REUTERS
·
Feb 17

BridgeBio price target raised to $100 from $90 at H.C. Wainwright

TIPRANKS
·
Feb 17

U.S. RESEARCH ROUNDUP-Brixmor Property, Mohawk Industries, UDR

Reuters
·
Feb 17

Kyowa Kirin Announces Positive Phase 3 Results for Infigratinib in Achondroplasia

Reuters
·
Feb 16

U.S. RESEARCH ROUNDUP-Applied Materials, Humana, Waste Connections

Reuters
·
Feb 13

BridgeBio Pharma CEO Neil Kumar Reports Disposal of Common Shares

Reuters
·
Feb 13

BridgeBio Oncology Therapeutics to Present at Major Healthcare Investor Conferences

Reuters
·
Feb 13

BridgeBio price target raised to $100 from $85 at Jefferies

TIPRANKS
·
Feb 13

BUZZ-U.S. STOCKS ON THE MOVE-FedEx Corp, Lincoln National

Reuters
·
Feb 13